Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $95.6800 (-0.54%) ($94.1200 - $98.7700) on Mon. Mar. 19, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.71% (three month average) | RSI | 48 | Latest Price | $95.6800(-0.54%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SONN declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) SDY(19%) XAR(19%) IWN(18%) QQQ(18%) SKYY(18%) | Factors Impacting SONN price | SONN will decline at least -3.355% in a week (0% probabilities). VCSH(-30%) LQD(-22%) TLT(-21%) CEMB(-19%) DIA(-17%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.355% (StdDev 6.71%) | Hourly BBV | 0 () | Intraday Trend | 1.7% | | | |
|
5 Day Moving Average | $95(0.72%) | 10 Day Moving Average | $93.54(2.29%) | 20 Day Moving Average | $94.64(1.1%) | To recent high | -10.7% | To recent low | 49.6% | Market Cap | $880m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |